| G-CSF in patients suffering from late revascularized ST elevation myocardial infarction: analysis on the timing of G-CSF administration. | |
| | |
MedLine Citation:
|
PMID: 18346835 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Granulocyte colony-stimulating factor (G-CSF) improves myocardial function after infarction in vivo. Placebo-controlled clinical studies failed to show beneficial effects on myocardial function. Recent data demonstrate that the time point of treatment initiation may be crucial for the efficacy of G-CSF. We investigated the influence of the timing of G-CSF treatment on myocardial function and perfusion in a subgroup study of the G-CSF-ST Elevation Myocardial Infarction trial. MATERIALS AND METHODS: Patients with late revascularized myocardial infarction (n = 44) were treated with either G-CSF or placebo over 5 days after successful percutaneous coronary intervention (PCI). Of the G-CSF group, 13 patients had received G-CSF early treatment started within 24 hours after PCI (mean: 16 +/- 6 hours). In 10 patients, G-CSF was initiated late (>24 hours after PCI, mean: 49 +/- 26 hours). Global and regional myocardial function and perfusion were assessed from baseline to 3 months after PCI using magnetic resonance imaging in 37 patients who completed magnetic resonance follow-up. RESULTS: G-CSF was safe when used early or late after PCI. Early G-CSF administration resulted in significantly improved perfusion at rest 1 month after PCI when compared to placebo (Up-slope, signal intensity 1.2 [0.4-1.8] vs 0.6 [0.1-1.3], p = 0.03). Timing of G-CSF had no influence on global and regional function. CONCLUSION: This post-hoc analysis indicates that timing of G-CSF after myocardial infarction does not improve myocardial function but myocardial perfusion if the cytokine is given early. This urges the need to investigate alternative dosage regimens or combination with novel therapeutics promoting mobilization and homing. |
| | |
Authors:
|
Markus G Engelmann; Hans D Theiss; Christine Theiss; Armin Huber; Bernd J Wintersperger; Anja E Werle-Ruedinger; Stefan O Schoenberg; Gerhard Steinbeck; Wolfgang-M Franz |
Related Documents
:
|
10728945 - Timing of and risk factors for myocardial ischemic events after percutaneous coronary i... 12151685 - Rescue percutaneous coronary intervention for failed thrombolysis: results from a distr... 19693675 - A 60-s postconditioning protocol by percutaneous coronary intervention inhibits myocard... 23512625 - Cardiac toxicity of anticancer agents. 17439655 - Ulcerated calcification of the interventricular septum causing transient ischemic attac... 10415225 - Emergent right coronary artery thrombectomy with a jet aspiration thrombectomy catheter. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2008-03-17 |
Journal Detail:
|
Title: Experimental hematology Volume: 36 ISSN: 0301-472X ISO Abbreviation: Exp. Hematol. Publication Date: 2008 Jun |
Date Detail:
|
Created Date: 2008-05-13 Completed Date: 2008-08-05 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0402313 Medline TA: Exp Hematol Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 703-9 Citation Subset: IM |
Affiliation:
|
Medical Department I-Cardiology, Ludwig Maximilians University, Klinikum Grosshadern, Munich, Germany. markus.engelmann@med.uni-muenchen.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Drug Administration Schedule Female Granulocyte Colony-Stimulating Factor / administration & dosage, therapeutic use* Hematopoietic Stem Cell Mobilization Humans Magnetic Resonance Imaging Male Middle Aged Myocardial Infarction / drug therapy*, pathology Myocardial Revascularization Stem Cell Transplantation Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
143011-72-7/Granulocyte Colony-Stimulating Factor |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Structural stability and reversible unfolding of recombinant porcine S100A12.
Next Document: Rapid platelet turnover in WASP(-) mice correlates with increased ex vivo phagocytosis of opsonized ...